Evidence map›Paper›PMID 24043460›Full record

ReviewAmino acids2013

Lysine metabolism in mammalian brain: an update on the importance of recent discoveries.

André Hallen, Joanne F Jamie, Arthur J L Cooper

Open access · bronzeAbstract readReview
In one paragraph

Review in Amino acids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 142 citations in OpenAlex.

  1. Anaplerotic therapy in propionic acidemia.Molecular genetics and metabolism · 2017
    Trial
  2. Trial
  3. Alkamines reveal a hidden layer of steroid and drug metabolism.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Marine life science & technology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. LysineFrontiers in molecular neuroscience · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

André HallenDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Balaclava Road, North Ryde, NSW, 2109, Australia, andre.hallen@mq.edu.au.
Joanne F Jamie
Arthur J L Cooper
Macquarie University · AUNew York Medical College · US

Funding

MECHANISM OF GLUTATHIONE CONJUGATE DEPENDENT TOXICITYR01ES008421 · NIEHS · WINIFRED MASTERSON BURKE MED RES INST · PI COOPER, ARTHUR JOSEPH · 1997 to 2007
$2.0M
NIEHS NIH HHS R01 ES008421NIEHS NIH HHS R01 ES8421
6 · The paper itself

Abstract

The lysine catabolism pathway differs in adult mammalian brain from that in extracerebral tissues. The saccharopine pathway is the predominant lysine degradative pathway in extracerebral tissues, whereas the pipecolate pathway predominates in adult brain. The two pathways converge at the level of ∆(1)-piperideine-6-carboxylate (P6C), which is in equilibrium with its open-chain aldehyde form, namely, α-aminoadipate δ-semialdehyde (AAS). A unique feature of the pipecolate pathway is the formation of the cyclic ketimine intermediate ∆(1)-piperideine-2-carboxylate (P2C) and its reduced metabolite L-pipecolate. A cerebral ketimine reductase (KR) has recently been identified that catalyzes the reduction of P2C to L-pipecolate. The discovery that this KR, which is capable of reducing not only P2C but also other cyclic imines, is identical to a previously well-described thyroid hormone-binding protein [μ-crystallin (CRYM)], may hold the key to understanding the biological relevance of the pipecolate pathway and its importance in the brain. The finding that the KR activity of CRYM is strongly inhibited by the thyroid hormone 3,5,3'-triiodothyronine (T3) has far-reaching biomedical and clinical implications. The inter-relationship between tryptophan and lysine catabolic pathways is discussed in the context of shared degradative enzymes and also potential regulation by thyroid hormones. This review traces the discoveries of enzymes involved in lysine metabolism in mammalian brain. However, there still remain unanswered questions as regards the importance of the pipecolate pathway in normal or diseased brain, including the nature of the first step in the pathway and the relationship of the pipecolate pathway to the tryptophan degradation pathway.

Indexed as

AnimalsBiocatalysisBrainHumansLysinemu-CrystallinsOxidoreductases Acting on CH-NH Group DonorsCRYM protein, humanketimine reductaseLysinemu-CrystallinsOxidoreductases Acting on CH-NH Group Donors

Identifiers

PMID24043460
PMCPMC3838446
OpenAlexW2034533322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.